Healthpeak Properties, Inc. (DOC) — Fair Value Analysis

Base-case fair value (P50): $26.02 · Current price: $21.89 · Verdict: Undervalued

The Verdict on DOC

Healthpeak Properties (DOC) receives a Deeply Overvalued verdict, according to our Monte Carlo simulations. While the median fair value (P50) suggests a target of $26.02, offering a potential +18.9% from its current trading price of $21.89, this median outlook must be viewed within the context of the full simulated distribution. The $26.02 indicates where the stock might settle in a central scenario, but our overall "Deeply Overvalued" assessment incorporates a broader range of outcomes, including those that present significant downside risk. This suggests that despite the positive median gap, the prevailing market price of $21.89 doesn't adequately reflect the aggregate risk profile as modeled.

How DOC stacks up against Real Estate

Operating in the Real Estate sector, DOC's quality tier is currently "unrated." This "unrated" status implies that Healthpeak Properties doesn't demonstrably outperform or underperform its sector peers in terms of operational or financial health. When assessing DOC's current price of $21.89 against its Monte Carlo-derived median fair value of $26.02, the implied +18.9% might seem appealing at first glance. However, the "Deeply Overvalued" verdict for DOC underscores that a simple comparison of $21.89 to $26.02 doesn't tell the complete story, especially within an unrated context. The lack of a clear quality advantage in the Real Estate sector, coupled with the overall valuation verdict, suggests caution.

What this means for investors

For investors analyzing Healthpeak Properties, the critical takeaway is the "Deeply Overvalued" assessment, despite the Monte Carlo P50 suggesting a +18.9% to a fair value of $26.02 from the current $21.89. This nuanced outlook indicates that the market currently prices DOC above a level justified by its probabilistic future cash flows, particularly when considering the broader distribution of outcomes, not just the median. Given DOC's unrated quality tier in the Real Estate sector, the "Deeply Overvalued" conclusion signals that risks potentially outweigh the upside suggested by the $26.02. FairCurve's framework helps contextualize these valuations. To understand the full bear-case and bull-case scenarios and track DOC's fair value as new fundamentals are released, sign up for a free FairCurve account.